Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about indicted drug wholesalers, a gene therapy rejection, and more

    by Ed Silverman Jul 01, 2024 1 minute
    Source: Alex Hogan/STAT

    Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the familiar routine of online meetings, calls, and deadlines has predictably returned. But you know, the

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Ozempic And An Eye Condition, A Failed Roche Cancer Drug Trial, And More
    A study reported for the first time a potential link between Novo Nordisk's GLP-1 drugs and an eye condition that can cause vision loss.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Probing Teva Patents, A Moderna Flu Vaccine Contract, And More
    The FTC is investigating Teva Pharmaceuticals after it refused to remove about two dozen patents for asthma and COPD inhalers from a federal registry.
    STAT1 min read
    STAT+: How A Tweet About A Gene Discovered Long Ago Led To A $190 Million Startup And, Maybe, Hope For Heart Disease
    A 10-person startup called Marea has raised $190 million to help develop a drug to lower a type of cholesterol and a new way of attacking cardiovascular disease.

    Related Books & Audiobooks